Dosing & Administration

THE FIRST ASTHMA BIOLOGIC WITH AT-HOME SELF-ADMINISTRATION OR IN-OFFICE ADMINISTRATION1

Recommended dosing schedules:


DUPIXENT is intended for use under the guidance of a healthcare provider. A patient may self-inject DUPIXENT after training in subcutaneous injection technique using the pre-filled syringe. Provide proper training to patients and/or caregivers on the preparation and administration of DUPIXENT prior to use according to the Instructions for Use.

  • DUPIXENT can be administered in the office under the guidance of a healthcare provider if the patient is not an appropriate candidate for self-administration
  • DUPIXENT is also indicated for the treatment of patients aged 12 years and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids
  • a200 mg=1.14 mL solution.
  • b300 mg=2 mL solution.

DUPIXENT OFFERS A PATH TO ASTHMA CONTROL

This presentation includes the fixed properties of these biologics. It is not intended to compare their safety, effectiveness, or uses. Please refer to each product’s Prescribing Information for approved indication and dosing and administration information.

  • Xolair is indicated for moderate to severe persistent asthma in patients 6 years of age and older who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.2

DUPIXENT MyWay®

See how eligible patients can access support for DUPIXENT

LEARN MORE

LEARN MORE ABOUT DUPIXENT

as add-on maintenance therapy
in moderate-to-severe asthma patients

REGISTER FOR UPDATES


    References:
  1. DUPIXENT Prescribing Information. March 2019.
  2. Xolair Prescribing Information. September 2018.
  3. Nucala Prescribing Information. December 2017.

  4. Fasenra Prescribing Information. November 2017.
  5. Cinqair Prescribing Information. May 2016.